Cubist Systematic Strategies’s ESSA Pharma EPIX Stock Holding History

Cubist Systematic Strategies’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,115	Closed	-$22.3K	–	3252
2025 Q1	$22.3K	Sell	14,115 -12,172	-46%	-$20.6K	﹤0.01%	2743
2024 Q4	$47.1K	Buy	+26,287	New	+$83.7K	﹤0.01%	2788
2023 Q1	–	Sell	-34,086	Closed	-$85.9K	–	4028
2022 Q4	$85.9K	Sell	34,086 -21,528	-39%	-$61.8K	﹤0.01%	3829
2022 Q3	$101K	Buy	55,614 +25,715	+86%	+$67.8K	﹤0.01%	4014
2022 Q2	$94K	Sell	29,899 -12,000	-29%	-$67K	﹤0.01%	3987
2022 Q1	$259K	Buy	+41,899	New	+$368K	﹤0.01%	2920
2021 Q4	–	Sell	-34,828	Closed	-$279K	–	3505
2021 Q3	$279K	Buy	+34,828	New	+$554K	﹤0.01%	2400

Other funds holding EPIX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

DLD Asset Management New York $986M AUM 4.68% 1-Year Est. Return